FindTrial
Sign In

99mTc-DPD scintigraphy

DIAGNOSTIC_TEST2 trials

Sponsors

University of Leipzig, Katarzyna Holcman

Conditions

Cardiac AmyloidosisHeart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure NYHA Class IVHeart Failure With Mid Range Ejection FractionHeart Failure With Preserved Ejection FractionHypertrophy, Left VentricularTransthyretin Amyloidosis

Unknown Phase

CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis
CompletedNCT04862273
University of LeipzigCardiac Amyloidosis, Heart Failure NYHA Class II, Heart Failure NYHA Class III +4
Start: 2021-04-01End: 2024-12-01Updated: 2026-04-13
The Regional Scintigraphic DPD Uptake in Cardiac Transthyretin Amyloidosis.
NCT05814380
Katarzyna HolcmanTransthyretin Amyloidosis
Start: 2020-05-04End: 2024-03-01Target: 100Updated: 2023-04-19

Related Papers

The left ventricular mechanical dispersion as a marker of disease severity in transthyretin cardiac amyloidosis.
2025-11-27
Transthyretin-related amyloid cardiomyopathy: A single-center experience in southern Poland, an endemic area
Kardiologia Polska2025-07-30
[<sup>99m</sup>Tc]Tc-DPD SPECT/CT evaluation of right and left ventricular involvement in cardiac transthyretin amyloidosis.
2025-04-02
Pre-symptomatic scintigraphic and genetic cascade screening in cardiac transthyretin amyloidosis.
2024-11-142 citations
Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy
Clinical Research in Cardiology2022-03-3116 citations